![]() ![]() (Note: LinkDoc Technology postponed its IPO early on Thursday, July 8, 2021, ahead of its scheduled pricing that night for a July 9 trade date, amid the Chinese government’s increasing regulatory scrutiny of Chinese companies going public in the U.S. ![]() dollars for 2020, according to the prospectus. Note: Revenue and net loss figures are in U.S. ![]() Through these touchpoints, we also collect, with patient consent, full longitudinal patient data with outcomes, which then becomes part of the input into our continuous care platform and our LinkData System. ![]() These patient care centers provide patients access to innovative therapeutic solutions and medication services and serve as a point of patient engagement with our digital continuous care platform. Our platform has become the largest oncology patient-centric continuous care platform in China, according to Frost & Sullivan.Īs part of our digital continuous care platform, we have also built a growing nationwide network of 34 patient care centers as of March 31, 2021, increasing from 24 in the beginning of 2019, covering 28 provinces. Since April 2015, we have cumulatively cared for over 3.5 million patients and provided longitudinal care for over 2.5 million patients. We conduct personalized follow-up care through our call centers and online channels, and allow patients to consult physicians online via our Internet hospital and receive personalized disease management services. Working with healthcare providers and life sciences companies, we have conducted a large-scale multi-center retrospective study with a sample of 10,000 Chinese lung cancer patients, which demonstrated that our LinkCare Platform has improved patients’ survival rates meaningfully. The platform integrates online and offline channels to help patients, especially those who suffer from cancer, better manage their illnesses as a chronic condition in and out of hospital. LinkCare Platform is a patient-centric digital continuous care platform for patients with critical diseases. We have successfully built China’s largest data-driven digital infrastructure for precision medicine, according to Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption. We are a leading data-driven and AI-enabled healthcare technology company in terms of being a first mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan. ![]()
0 Comments
Leave a Reply. |